Le Lézard
Classified in: Health
Subjects: HEALTH, MISCELLANEOUS, MISCELLANEOUS

LifeLabs named one of Canada's Best Employers for Diversity by Forbes for second consecutive year


Toronto, Ontario, July 12, 2023 (GLOBE NEWSWIRE) -- LifeLabs has been named one of Canada's Best Employers for Diversity in 2023 by Forbes and is the only organization to be honoured in the category of Health Care Equipment & Services. This is the second consecutive year LifeLabs has been recognized by Forbes. 

Forbes presented this prestigious award in partnership with Statista, the world-leading statistics portal and industry ranking provider. The Best Employers for Diversity list recognizes Canadian companies that have demonstrated a significant commitment to a defined strategy to foster and promote diversity, equity, inclusion and accessibility in their workplace culture, recruitment practices and employee education and training.

Recipients were selected based on the assessments of approximately 10,000 professionals working for companies employing at least 500 people in their Canadian operations, and were surveyed to identify Canada's Best Employers for Diversity. The following four criteria were taken into consideration:

"Such recognition is a privilege and a testament to our ongoing efforts to promote equity and social justice," says LifeLabs President and CEO Charles Brown, "While we have undoubtedly made strides in our endeavour to become a DEI-driven organization, we firmly believe that our Stronger Together program empowers us to push the boundaries of our commitment and continuous improvement. We will continue to amplify our efforts in fostering an inclusive workplace for our team members and a healthcare environment for Canadians."

LifeLabs' continued investment in a comprehensive DE&I strategy has brought forth valuable programs, initiatives, and leadership that continue to make meaningful impacts and facilitate future development and innovation in this area:

We are also continuing to identify and invest in new education opportunities for our teams, including the launch of our Stronger Together Lunch & Learn series and continuing to work with partners, like Pride at Work Canada, to collaborate on learnings that will provide our employees with the knowledge, language and skills to truly embody our values and commitment to diversity, equity and inclusion.

As Canada's largest community laboratory, we want to lead the way in creating an environment that is accessible and equitable for all employees and customers alike. We recognize and appreciate the diverse experiences of our teams and the value that brings to building an inclusive environment for our customers.

More information about LifeLabs' DE&I initiatives can be found at: https://www.lifelabs.com/about-us/diversity-equity-inclusion/. To learn more about this award and to see the complete list of recipients, please visit the Forbes website.

About LifeLabs
LifeLabs is Canada's leading provider of laboratory diagnostic information and digital health connectivity systems, enabling patients and health care practitioners to diagnose, treat, monitor, and prevent disease. We support 20 million patient visits annually and conduct over 100 million laboratory tests through leading-edge technologies and our 6,500 talented and dedicated employees. We are a committed innovator in supporting Canadians to live healthier lives, operating Canada's first commercial genetics lab and the country's largest online patient portal, with more than 5 million Canadians receiving their results online. LifeLabs has been named one of Canada's Best Employers (2021,2022,2023) and Best Employers for Diversity (2022 and 2023) by Forbes and recognized for having an award-winning Mental Health Program from Benefits Canada. LifeLabs is 100% Canadian owned by OMERS Infrastructure, the infrastructure investment manager of one of Canada's largest defined benefit pension plans. Learn more at lifelabs.com.

Attachment



These press releases may also interest you

at 05:05
MiLaboratories, a leader in RNA immune technologies, and Miltenyi Biotec, a global pioneer in biotechnology, are excited to announce a landmark partnership that promises to revolutionize the field of next-generation therapies. This collaboration...

at 05:02
Immunovia AB (publ) today announced that the Annual Report for 2023 has been published.  The annual report can be downloaded in pdf format and is available on Immunovia's website: https://investor.immunovia.com/financial-reports-presentations/. For...

at 04:19
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that an abstract for the combination of fostroxacitabine bralpamide (fostrox) + Lenvima® in...

at 04:15
Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced the expansion of its LV Edge System with the launch of a fully stable cell line development service. There are now two ways for customers to...

at 04:07
Huma Therapeutics ("Huma"), a leader in global digital health innovation, together with Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the launch of their innovative bladder cancer treatment companion app in...

at 04:00
Calibre Scientific is pleased to announce the acquisition of Camlab Limited ("Camlab" or the "Company"), a UK-based supplier of scientific equipment, chemicals, consumables, labware, and other laboratory supplies and services to customers in the...



News published on and distributed by: